Review decisions
Showing 320 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00777
Product Type: Drug
Control Number: 237081
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-17
Decision / Authorization Date: 2021-02-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00805
Product Type: Drug
Control Number: 237113
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-17
Decision / Authorization Date: 2021-02-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00778
Product Type: Drug
Control Number: 236999
Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-11
Decision / Authorization Date: 2021-02-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00765
Product Type: Drug
Control Number: 239474
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-05-13
Decision / Authorization Date: 2021-02-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01015
Product Type: Drug
Control Number: 239505
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-05-15
Decision / Authorization Date: 2021-02-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00755
Product Type: Drug
Control Number: 236086
DIN(s): 02511576, 02511584
Manufacturer: Celltrion Healthcare Co., Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-02-18
Decision / Authorization Date: 2021-01-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00785
Product Type: Drug
Control Number: 235583
DIN(s): 02511517
Manufacturer: ViiV Healthcare ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-01-29
Decision / Authorization Date: 2021-01-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00762
Product Type: Drug
Control Number: 235994
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-02-11
Decision / Authorization Date: 2021-01-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00771
Product Type: Drug
Control Number: 235656
DIN(s): 02510243
Manufacturer: Bausch Health, Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-01-30
Decision / Authorization Date: 2021-01-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1701362974599
Product Type: Drug
Control Number: 247851
DIN(s): 02247238
Manufacturer: Bausch Health, Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-12-24
Decision / Authorization Date: 2023-09-14